|
1
|
Coulthard MG, Duffy S, Down M, Evans B,
Power M, Smith F, Stylianou C, Kleikamp S, Oates A, Lackmann M,
Burns GF and Boyd AW: The role of the Eph-ephrin signalling system
in the regulation of developmental patterning. Int J Dev Biol.
46:375–384. 2002.PubMed/NCBI
|
|
2
|
Klein R: Bidirectional signals establish
boundaries. Curr Biol. 9:R691–R694. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gale NW, Holland SJ, Valenzuela DM,
Flenniken A, Pan L, Ryan TE, Henkemeyer M, Strebhardt K, Hirai H,
Wilkinson DJ, Pawson T, Davis S and Yancoupoulos GD: Eph receptors
and ligands comprise two major specificity subclasses and are
reciprocally compartmentalised during embryogenesis. Neuron.
17:9–19. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Boyd AW and Lackmann M: Signals from Eph
and ephrin proteins: a developmental tool kit. Sci STKE.
112:re202001.PubMed/NCBI
|
|
5
|
Hirai H, Maru Y, Hagiwara K, Nishida J and
Takaku F: A novel putative tyrosine kinase receptor encoded by the
eph gene. Science. 238:1717–1720. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Batlle E, Henderson JT, Beghtel H, van den
Bron MM, Sancho E, Huls G, Meeldijk J, Robertson J, van de Wetering
M, Pawson T and Clevers H: Beta-Catenin and TCF mediate cell
positioning in the intestinal epithelium by controlling the
expression of EphB/ephrin B. Cell. 111:251–263. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Batlle E, Bacani J, Begthel H, Jonkheer S,
Gregorieff A, van de Born M, Malats N, Sancho E, Boon E, Pawson T,
Gallinger S, Pals S and Clevers H: EphB receptor activity
suppresses colorectal cancer progression. Nature. 435:1126–1130.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kataoka H, Tanaka M, Kanamori M, Yoshii S,
Ihara M, Wang YJ, Song JP, Li ZY, Arai H, Otsuki Y, Kobayashi T,
Konno H, Hanai H and Sugimura H: Expression profile of EFNB1,
EFNB2, two ligands of EPHB2 in human gastric cancer. J Cancer Res
Clin Oncol. 28:343–348. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stephenson SA, Slomka S, Douglas EL,
Hewett PJ and Hardingham JE: Receptor protein tyrosine kinase EphB4
is up-regulated in colon cancer. Int J Dev Biol. 46:375–384.
2002.
|
|
10
|
Berclaz G, Flutsch B, Altermatt HJ,
Rohrback H, Djonov V, Ziemiecki A, Dreher E and Andres AC: Loss of
EphB4 receptor tyrosine kinase protein expression during
carcinogenesis of the human breast. Pain. 139:168–180. 2008.
|
|
11
|
Nikolova Z, Djonov V, Zuercher G, Andres
AC and Ziemiecki A: Cell-type specific and estrogen dependent
expression of the receptor tyrosine kinase EphB4 and its ligand
ephrin B2 during mammary gland morphogenesis. J Cell Sci.
111:2741–2751. 1998.PubMed/NCBI
|
|
12
|
Liu W, Ahmad SA, Jung YD, Reinmuth N, Fan
F, Bucana CD and Ellis LM: Co-expression of ephrin-Bs and their
receptors in colon carcinoma. Cancer. 94:934–939. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Dang C, Ma Q and Shimahara Y:
Expression of nerve growth factor receptors and their prognostic
value in human pancreatic cancer. Oncol Rep. 14:161–171.
2005.PubMed/NCBI
|
|
14
|
Holmberg J and Frisen J: Ephrins are not
only unattractive. Trends Neurosci. 25:239–243. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kobayashi H, Kitamura T, Sekiguchi M,
Homma MK, Kabuyama Y, Konno S, Kikuchi S and Homma Y: Involvement
of EphB1 receptor/EphrinB2 ligand in neuropathic pain. Spine (Phila
Pa 1976). 32:1592–1598. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song XJ, Zheng JH, Cao JL, Liu WT, Song XS
and Huang ZJ: EphrinB-EphB receptor signaling contributes to
neuropathic pain by regulating neural excitability and spinal
synaptic plasticity in rats. Pain. 139:168–180. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mao W, Luis E, Ross S, Silva J, Tan C,
Crowley C, Chui C, Franz G, Senter P, Koeppen H and Polakis P:
EphB2 as a therapeutic antibody drug target for the treatment of
colorectal cancer. Cancer Res. 64:781–788. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Toledo-Sherman L, Deretey E,
Slon-Usakiewicz JJ, Ng W, Dai JR, Foster JE, Redden PR, Uger MD,
Liao LC, Pasternak A and Reid N: Frontal affinity chromatography
with MS detection of EphB2 tyrosine kinase receptor. 2
Identification of small-molecule inhibitors via coupling with
virtual screening. J Med Chem. 48:3221–3230. 2005. View Article : Google Scholar
|
|
19
|
Koolpe M, Burgess R, Dail M and Pasquale
EB: EphB receptor-binding peptides identified by phage display
enable design of an antagonist with ephrin-like affinity. J Biol
Chem. 280:17301–17311. 2005. View Article : Google Scholar : PubMed/NCBI
|
